Product Information
DONEPEZIL HCL 5 MG TABLET is a generic product labeled by ACI Healthcare USA, Inc., priced at $0.0440 per EA under NDC 71093012703. Its NADAC has been published 241 times since Feb 23, 2022.
FDA first approved this application on May 31, 2011.
Strength
5 mg/1
Manufacturer
ACI Healthcare USA, Inc.NDC
71093012703
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DONEPEZIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078662FDA Approved
5/31/2011
On Market Since
6/29/2021
Pharmacological Classes
Price Statistics
The NADAC for DONEPEZIL HCL 5 MG TABLET has been published 241 times since Feb 23, 2022, and over the history we have for it it has declined 18.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0440 per EA |
|---|---|
| All-time high | $0.0540 (Mar 16, 2022) |
| All-time low | $0.0334 (May 22, 2024) |
| 52-week high | $0.0446 |
| 52-week low | $0.0424 |
| Median price | $0.0445 |
| Average price | $0.0447 |
| Largest weekly change | +28.3% (Nov 22, 2023) |
| Weeks tracked | 241 |
| Tracking since | Feb 23, 2022 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ACI Healthcare USA, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Donepezil Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DONEPEZIL HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DONEPEZIL HCL 5 MG TABLET, manufactured by ACI Healthcare USA, Inc., is $0.0440 per EA (NDC 71093012703), effective Sep 30, 2026.
How has the price of DONEPEZIL HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for DONEPEZIL HCL 5 MG TABLET has declined 18.6%. It has been tracked across 241 weekly CMS publications since Feb 23, 2022.
What are the highest and lowest recorded NADAC prices for DONEPEZIL HCL 5 MG TABLET?
Since Feb 23, 2022, the NADAC for DONEPEZIL HCL 5 MG TABLET has ranged from a low of $0.0334 (May 22, 2024) to a high of $0.0540 (Mar 16, 2022), with a median of $0.0445 per EA.
Are there cheaper alternatives to DONEPEZIL HCL 5 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DONEPEZIL HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DONEPEZIL HCL 5 MG TABLET?
DONEPEZIL HCL 5 MG TABLET (NDC 71093012703) is labeled by ACI Healthcare USA, Inc., and CMS classifies it as a generic product.